Eight Sleep's new Pregnancy Mode adjusts your bed temperature so you don't have to. The sleep tech company's latest feature tracks physiological changes during pregnancy and postpartum to automatically fine-tune your sleep. Nasha Addarich Martínez May 5, 2026 6:00 a.m. PT If you've ever been pregnant (or know someone who has), you know that sleep gets harder as the pregnancy progresses. One minute you're freezing, the next you're waking up to night sweats. Most likely, your sleep environment hasn't changed, but your body has. Eight Sleep, the company behind the Pod smart mattress cover and sleep tracker, just launched Pregnancy Mode, an AI-powered system built for the physiological changes brought on from pregnancy and postpartum. It's available now as a free app update for all Eight Sleep members with a paid Standard, Enhanced or Elite subscription ($17 to $33 per month). When you activate Pregnancy Mode within the app, the system uses your pre-pregnancy temperature baseline, your last menstrual period date and your estimated due date to automatically calculate weekly temperature adjustments across all sleep stages. Eight Sleep's dataset of over 100 pregnant members and 50,000 nights of sleep data found that in the early stages of pregnancy, your body tends to sleep warmer (about 0.4 to 0.7 degrees Fahrenheit) than your pre-pregnancy baseline temperature. The study also found that by the third trimester, it's the complete opposite - pregnant people were setting their Pods nearly 3.5 degrees cooler than normal. Pregnancy Mode also tracks that curve and continues to adjust eight weeks postpartum. The feature includes a dedicated Pregnancy Insights card in the app, where you can see weekly biometric summaries of your heart rate, heart rate variability, respiratory rate, sleep stages and snoring. It'll also compare these metrics to your pre-pregnancy scores. Baby development milestones and prenatal visit reminders are part of this new feature, too. Partners sharing the bed will get their own weekly insights on what to expect and how to help their pregnant significant other. Pregnancy Mode is now available in the Eight Sleep app on iOS and Android. The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives. Other sleep guides. Bed Accessories Sleep Tech NASHA ADDARICH MARTÍNEZ Managing Editor Nasha is a Managing Editor for CNET, overseeing its sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic practices transcends her personal life and profoundly influences her editorial approach, as she weaves evidence-based insights with practical advice to inspire readers to lead healthier, more balanced lives. Throughout her career, she's covered various topics including financial services, technology, travel and wellness. See full bio

Q1's unicorns: from sleep optimization to blockchain intelligence. By Chris Cannon Updated on April 6, 2026 The first quarter of 2026 has already produced a new cohort of unicorns spanning health tech, AI infrastructure, climate intelligence, biotech manufacturing and crypto compliance. From sleep optimization to blockchain intelligence, this latest group of companies reaching $1 billion valuations reflects a broader shift toward businesses embedding intelligence into real-world systems. Below, Forge Global, Inc. highlight five companies that achieved coveted unicorn status in Q1 2026. Eight Sleep, an AI-powered sleep system. New York City-based Eight Sleep is first on the list, having achieved unicorn status in Q1 2026. In March, the company closed a $50 million Series D funding round, bringing its post-money valuation to $1.5 billion.[1] Founded in 2014, Eight Sleep develops AI-powered sleep systems, including its flagship "Pod," which integrates biometric sensors and temperature regulation to optimize sleep performance.[2] The company noted that the latest capital raise will support expansion into clinical validation, FDA pathways, and a broader vision of proactive health monitoring, effectively transforming the bedroom into a continuous health data platform.[3] Eight Sleep has also been expanding its global footprint. In 2025, the company entered the Asia market with a suite of products launched in China and Singapore, and at the time indicated potential plans for a future public listing.[4] As of March 31, 2026, Eight Sleep's Forge Price(TM) is $3.50, implying a valuation of $653.80 million. Notable investors include Valor Equity Partners, Y Combinator, Founders Fund and SoftBank. Talos, a digital portfolio management platform. New York City-based Talos is next on the list, reaching unicorn status following a Series B funding round in January 2026 that valued the company at $1.5 billion. Founded in 2018, Talos provides trading and portfolio management software for institutional investors operating in digital asset markets. Its platform connects liquidity providers, exchanges and custodians into a unified system, enabling more efficient execution and streamlined risk management.[5] Since its founding, Talos has reportedly supported over $727 billion in trading volume, underscoring its growing role in institutional crypto infrastructure. The company plans to use its latest capital infusion to accelerate product development and expand its offerings across multiple digital asset classes.[6] Talos' last price per share was $50.02 as of its most recent funding round (Series B) on January 29, 2026.[7] Notable investors include General Atlantic, PayPal Ventures, Fidelity and Wells Fargo. Cellares, a healthcare company. In January 2026, healthcare company Cellares reached unicorn status after closing a $257 million Series D funding round at a $1.37 billion valuation. Founded in 2019, Cellares is a cell therapy manufacturer focused on developing scalable solutions to accelerate treatment access for patients across a range of diseases. The company noted that its latest capital raise will support the commercial launch of its cell therapies, with the goal of expanding access to thousands of patients each year.[8] Central to its platform is the Cell Shuttle, an automated system that enables end-to-end manufacturing of cell therapies. The technology was recognized as one of TIME's Best Inventions of 2025.[9] San Francisco-based Cellares reported a price per share of $11.99 as of its Series D round. Notable investors include BlackRock, Eclipse Ventures, T. Rowe Price and Bristol Myers Squibb. Tomorrow.io, a weather intelligence firm. Boston-based Tomorrow.io reached unicorn status in February 2026 after closing a $175 million Series F funding round, bringing its post-money valuation to $1 billion. Founded in 2015, Tomorrow.io is a weather intelligence company focused on delivering hyper-local, short-term forecasts. Its real-time solutions support decision-making across industries including aviation, logistics and government.[10] The company's differentiated approach combines proprietary data collection, such as satellite infrastructure, with AI-driven forecasting models. In January, Tomorrow.io unveiled "DeepSky," a constellation of satellites designed to provide atmospheric data to power AI models.[11] As of its most recent funding round (Series F) on February 3, 2026, Tomorrow.io's share price was $5.45 [12] Notable investors include Activate Capital, Square Peg Capital and HarbourVest. TRM Labs, an AI-powered crypto detective. San Francisco-based TRM Labs joined the unicorn ranks in February 2026 after closing a $70 million funding round that valued the fintech company at $1 billion. Founded in 2017, TRM Labs provides AI-powered tools that help governments, law enforcement and financial institutions detect and prevent illicit crypto activity. As digital asset adoption accelerates and regulatory scrutiny intensifies, the company is emerging as a critical infrastructure layer for financial integrity and national security.[13] More recently, TRM Labs introduced Co-Case Agent(TM), an AI investigative assistant designed to translate natural language prompts into actionable intelligence, streamlining complex blockchain investigations.[14] TRM Labs' last price per share was $24.74 as of its latest Series C funding round, February 4,2026.[15] Notable investors include Blockchain Capital, Goldman Sachs, Bessemer Venture Partners and Y Combinator.

Eight Sleep said it was free-cash-flow positive in 2025 and plans to use the new funding for new products, global expansions, and clinical validation.